About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Oral Abstract NHL 102: Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Sattva Neelapu
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Sattva Neelapu
99 views
October 25, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Session VIII: Non-Hodgkin Lymphoma
17:19
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Follicular Lymphoma - Bendamustine and Rituximab as Preferred Treatm…
Feat.
M. Rummel
18:05
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Managing High Risk/Relapsed Follicular Lymphoma
Feat.
N. Fowler
16:02
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Do We Need Maintenance Anti-CD20 Antibody After RCHOP/R-Chem…
Feat.
M. Rummel
12:43
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Advances in the Treatment of Primary Central Nervous System Lymphoma
Feat.
C. Melani
16:44
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
How I Treat Double Hit Lymphoma
Feat.
K. Dunleavy
08:33
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 049: Second Primary Malignancies in T-cell Neoplas…
Feat.
A. Kommalapati
07:40
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 088: Angiogenesis’ Related Polymorphism Emerges as…
Feat.
A. Brito
06:36
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 102: Axicabtagene Ciloleucel in Patients With Refr…
Feat.
S. Neelapu
06:56
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 122: Durability of Response in Patients With Refra…
Feat.
S. Neelapu
